| Tretinoin | Approved Investigational Nutraceutical | HOXB3 | 3213 |
upregulated | Tretinoin results in increased expression of HOXB3 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB4 | 3214 |
upregulated | Tretinoin results in increased expression of HOXB4 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB5 | 3215 |
upregulated | Tretinoin results in increased expression of HOXB5 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB6 | 3216 |
upregulated | Tretinoin results in increased expression of HOXB6 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB7 | 3217 |
upregulated | Tretinoin results in increased expression of HOXB7 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB8 | 3218 |
upregulated | Tretinoin results in increased expression of HOXB8 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXB9 | 3219 |
upregulated | Tretinoin results in increased expression of HOXB9 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXC4 | 3221 |
upregulated | Tretinoin results in increased expression of HOXC4 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXC5 | 3222 |
upregulated | Tretinoin results in increased expression of HOXC5 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXC6 | 3223 |
upregulated | Tretinoin results in increased expression of HOXC6 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXC9 | 3225 |
upregulated | Tretinoin results in increased expression of HOXC9 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXD1 | 3231 |
upregulated | Tretinoin results in increased expression of HOXD1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXD10 | 3236 |
upregulated | Tretinoin results in increased expression of HOXD10 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXD3 | 3232 |
upregulated | Tretinoin results in increased expression of HOXD3 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HOXD4 | 3233 |
upregulated | Tretinoin results in increased expression of HOXD4 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HPCAL1 | 3241 |
upregulated | Tretinoin results in increased expression of HPCAL1 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HPD | 3242 |
upregulated | Tretinoin results in increased expression of HPD mRNA | 12q24.31 | |
| Tretinoin | Approved Investigational Nutraceutical | HPDL | 84842 |
downregulated | Tretinoin results in decreased expression of HPDL mRNA | 1p34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HPGD | 3248 |
upregulated | Tretinoin results in increased expression of HPGD mRNA | 4q34.1 | |
| Tretinoin | Approved Investigational Nutraceutical | HPRT1 | 3251 |
downregulated | Tretinoin results in decreased expression of HPRT1 mRNA | Xq26.2-q26.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HPS3 | 84343 |
upregulated | Tretinoin results in increased expression of HPS3 mRNA | 3q24 | |
| Tretinoin | Approved Investigational Nutraceutical | HPSE | 10855 |
upregulated | Tretinoin results in increased expression of HPSE mRNA | 4q21.23 | |
| Tretinoin | Approved Investigational Nutraceutical | HR | 55806 |
downregulated | Tretinoin results in decreased expression of HR mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | HRH3 | 11255 |
downregulated | Tretinoin results in decreased expression of HRH3 mRNA | 20q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | HS3ST1 | 9957 |
downregulated | Tretinoin results in decreased expression of HS3ST1 mRNA | 4p15.33 | |